Lennar Edges Higher;Verve Therapeutics Soars; T-Mobile Slides
On this episode of Stock Movers:- Lennar (LEN) is edging higher after a miss on the homebuilder’s new orders outlook was tempered by better-than-expected gross margins, which RBC Capital Markets said should reassure investors. Analysts including Mike Dahl say Lennar’s results came in better than feared on gross margin percentage with orders modestly missing, while the guide for a flat quarter-on-quarter gross margin percentage also surprised on the upside. Lennar’s second-quarter adjusted earning per share missed consensus estimates with higher selling, general, and…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.